ArticleFrontiers in oncology2023

The activity of a PI3K δ-sparing inhibitor, MEN1611, in non-small cell lung cancer cells with constitutive activation of the PI3K/AKT/mTOR pathway.

Giuliana Papoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.